1. |
Valdespino VM, Valdespino VE. Cervical cancer screening:state of the art[J]. Curr Opin Obstet Gynecol, 2006, 18(1):35-40.
|
2. |
Kim SE, Huang H, Zhao M, et al. Wnt stabilization of β-catenin reveals principles for morphogen receptor-scaffold assemblies[J]. Science, 2013, 340(6134):867-870.
|
3. |
Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010:a systematic analysis[J]. Lancet, 2011, 378(9801):1461-1484.
|
4. |
Chandrashekar C, Angadi PV, Krishnapillai R. β-Catenin expression in benign and malignant salivary gland tumors[J]. Int J Surg Pathol, 2011, 19(4):433-440.
|
5. |
Ferrazzo KL, Neto MM, Dos Santos E, et al. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands[J]. J Oral Pathol Med, 2009, 38(9):701-707.
|
6. |
Guha P, Kaptan E, Bandyopadhyaya G, et al. Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis[J]. Proc Natl Acad Sci USA, 2013, 110(13):5052-5057.
|
7. |
De Oliveira JT, De Matos AJ, Gomes J, et al. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors:implications for tumor metastasis[J]. Glycobiology, 2010, 20(11):1341-1352.
|
8. |
Dakeng S, Duangmano S, Jiratchariyakul W, et al. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells:reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus[J]. J Cell Biochem, 2012, 113(1):49-60.
|
9. |
Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population[J]. Int J Cancer, 2002, 97(1):72-81.
|
10. |
Sant'ana JM, Chammas R, Liu FT, et al. Activation of the Wnt/Beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice[J]. Anticancer Res, 2011, 31(9):2805-2811.
|
11. |
Jawhari AU, Farthing MJ, Pignatelli M. The E-cadherin/epidermal growth factor receptor interaction:a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation[J]. J Pathol, 1999, 187(2):155-157.
|
12. |
Lee SB, Gong YD, Park YI, et al. 2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells[J]. Biochem Biophys Res Commun, 2013, 431(4):746-752.
|
13. |
Moody CA, Laimins LA. Human papillomavirus oncoproteins:pathways to transformation[J]. Nat Rev Cancer, 2010, 10(8):550-560.
|
14. |
George S, Barysauskas C, Serrano C, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma[J]. Cancer, 2014, 120(20):3154-3158.
|
15. |
Chen J, Yao D, Li Y, et al. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma[J]. Int J Mol Med, 2013, 32(3):557-567.
|
16. |
Shu XS, Geng H, Li L, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors[J]. PLos One, 2011, 6(11):e27346.
|
17. |
Samarzija I, Beard P. Hedgehog pathway regulators influence cervical cancer cell proliferation, survival and migration[J]. Biochem Biophys Res Commun, 2012, 425(1):64-69.
|